110 related articles for article (PubMed ID: 4800469)
1. Low remission after therapy for Graves disease. Possible relation of dietary iodine with antithyroid therapy results.
Wartofsky L
JAMA; 1973 Nov; 226(9):1083-8. PubMed ID: 4800469
[No Abstract] [Full Text] [Related]
2. Thyroid suppression test and outcome of hyperthyroidism treated with antithyroid drugs and triiodothyronine.
Yamamoto M; Igarashi T; Kimura S; Tsukamoto S; Togawa K; Ogata E
J Clin Endocrinol Metab; 1979 Jan; 48(1):72-7. PubMed ID: 581766
[No Abstract] [Full Text] [Related]
3. The use of the E-rosette as a test for remission in Graves' disease treated with antithyroid drugs.
Farid NR; Munro R; Row VV; Volpé R
Clin Endocrinol (Oxf); 1974 Jan; 3(1):55-61. PubMed ID: 4407296
[No Abstract] [Full Text] [Related]
4. [Clinical significance of elevated serum triiodothyronine to thyroxine ratios in patients with Graves' disease treated with antithyroid drugs].
Takamatsu J
Nihon Naibunpi Gakkai Zasshi; 1983 Mar; 59(3):295-303. PubMed ID: 6190686
[No Abstract] [Full Text] [Related]
5. Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease.
Greer MA; Kammer H; Bouma DJ
N Engl J Med; 1977 Jul; 297(4):173-6. PubMed ID: 69269
[TBL] [Abstract][Full Text] [Related]
6. Triiodothyronine toxicosis developing during antithyroid drug therapy for hyperthyroidism.
Hollander CS; Shenkman L; Mitsuma T; Asper SP
Johns Hopkins Med J; 1972 Aug; 131(2):184-8. PubMed ID: 5068365
[No Abstract] [Full Text] [Related]
7. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
Izumi M; Larsen PR
J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211
[TBL] [Abstract][Full Text] [Related]
8. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
9. Antithyroid drugs in practice.
Vanderlaan WP
Mayo Clin Proc; 1972 Dec; 47(12):962-5. PubMed ID: 4117991
[No Abstract] [Full Text] [Related]
10. Inappropriate suppression of thyrotropin during medical treatment of Graves disease in childhood.
Sills IN; Horlick MN; Rapaport R
J Pediatr; 1992 Aug; 121(2):206-9. PubMed ID: 1640284
[TBL] [Abstract][Full Text] [Related]
11. Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities.
Kuzuya N; Chiu SC; Ikeda H; Uchimura H; Ito K; Nagataki S
J Clin Endocrinol Metab; 1979 Apr; 48(4):706-11. PubMed ID: 581876
[No Abstract] [Full Text] [Related]
12. Restriction of dietary Iodine does not ameliorate the early effect of anti-thyroid drug therapy for Graves' disease in an area of excessive iodine intake.
Hiraiwa T; Ito M; Imagawa A; Takamatsu J; Kuma K; Miyauchi A; Hanafusa T
J Endocrinol Invest; 2006 Apr; 29(4):380-4. PubMed ID: 16699308
[TBL] [Abstract][Full Text] [Related]
13. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
14. Remission of Graves' disease is not related to early restoration of euthyroidism with high-dose methimazole therapy.
Kruljac I; Solter D; Vrkljan AM; Solter M
Endocr Res; 2015; 40(1):25-8. PubMed ID: 24833206
[TBL] [Abstract][Full Text] [Related]
15. Thionamide therapy in Graves' disease: relation of relapse rate to duration of therapy.
Tamai H; Nakagawa T; Fukino O; Ohsako N; Shinzato R; Suematsu H; Kuma K; Matsuzuka F; Nagataki S
Ann Intern Med; 1980 Apr; 92(4):488-90. PubMed ID: 6892672
[TBL] [Abstract][Full Text] [Related]
16. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
Buerklin EM; Schimmel M; Utiger RD
J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the relationship between labelled triiodothyronine and thyroxine levels in the serum of patients with Graves' disease.
Földes J; Gyertyánfy G; Tako J; Bános C; Gesztesi E
Endokrinologie; 1973 Jan; 61(1):52-64. PubMed ID: 4739850
[No Abstract] [Full Text] [Related]
18. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
19. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
Sato S; Noh JY; Sato S; Suzuki M; Yasuda S; Matsumoto M; Kunii Y; Mukasa K; Sugino K; Ito K; Nagataki S; Taniyama M
Thyroid; 2015 Jan; 25(1):43-50. PubMed ID: 25178068
[TBL] [Abstract][Full Text] [Related]
20. Antithyroid drug treatment of von Basedow's disease: results from a multicenter study.
Benker G; Nolte C; Olbricht T; Reinwein D; Kahaly G; Galvan G; Hackenberg K; Gräf KJ; Schneider HG; Ziegler R
Exp Clin Endocrinol; 1991 May; 97(2-3):252-6. PubMed ID: 1915641
[No Abstract] [Full Text] [Related]
[Next] [New Search]
